Search Results - "Poumian‐Ruiz, Ena"

Extended survival versus accelerated rejection of nonhuman primate islet allografts: Effect of mesenchymal stem cell source and timing by Kenyon, Norma S., Willman, Melissa A., Han, Dongmei, Leeman, Rachel S., Rabassa, Alex, Diaz, Waldo L., Geary, James C., Poumian‐Ruiz, Ena, Griswold, Anthony J., Van Booven, Derek J., Thompson, Ryan, Ordoukhanian, Philip, Head, Steven R., Kenyon, Norman M., McHenry, Kenton G., Salomon, Daniel R., Bartholomew, Amelia M., Berman, Dora M.

“…Mesenchymal stem cells (MSC) have been shown to be immunomodulatory, tissue regenerative, and graft promoting; however, several questions remain with regard to…”
Get full text

Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3γ1(Ala-Ala) by Herold, Kevan C., Burton, Joshua B., Francois, Fleur, Poumian-Ruiz, Ena, Glandt, Mariela, Bluestone, Jeffrey A.

Get full text

Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus by Herold, Kevan C, Hagopian, William, Auger, Julie A, Poumian-Ruiz, Ena, Taylor, Lesley, Donaldson, David, Gitelman, Stephen E, Harlan, David M, Xu, Danlin, Zivin, Robert A, Bluestone, Jeffrey A

“…Mechanisms that destroy beta cells in type 1 diabetes mellitus involve both cytotoxic T cells and soluble T-cell products. In the present study, 24 patients…”
Get full text

Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3γ1(Ala-Ala) by Herold, Kevan C., Burton, Joshua B., Francois, Fleur, Poumian-Ruiz, Ena, Glandt, Mariela, Bluestone, Jeffrey A.

“…Dimeric Fc receptor (FcR) nonbinding anti-CD3 antibodies have been developed to minimize toxicities associated with classical anti-CD3 monoclonal antibodies…”
Get full text

Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3(gamma)1(Ala-Ala) by Herold, Kevan C, Burton, Joshua B, Francois, Fleur, Poumian-Ruiz, Ena

“…Dimeric Fc receptor (FcR) nonbinding anti-CD3 antibodies have been developed to minimize toxicities associated with classical anti-CD3 monoclonal antibodies…”
Get full text

Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala) by Herold, Kevan C, Burton, Joshua B, Francois, Fleur, Poumian-Ruiz, Ena, Glandt, Mariela, Bluestone, Jeffrey A

“…Dimeric Fc receptor (FcR) nonbinding anti-CD3 antibodies have been developed to minimize toxicities associated with classical anti-CD3 monoclonal antibodies…”
Get full text